Biotech · Private company
AxeroVision, Inc.
Track this companyFree. Adds AxeroVision, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AXR-159Phase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- AXR-270 High DosePhase 2 · Posterior BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- AXR-270 Low DosePhase 2 · Posterior BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- AXR-270 VehiclePhase 2 · Posterior BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland DysfunctionPHASE2 · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04469998 · fetched Nov 12, 2026
- A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye DiseasePHASE2 · COMPLETED · started Jun 26, 2018ClinicalTrials.gov NCT03598699 · fetched Nov 12, 2026